Factors associated with adherence to follow-up calls in cancer patients receiving care at a community oncology practice.
Shanada MonestimeRay PageNicole ShawRandy MartinWilliam JordanJessica RangelSubhash AryalPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
For patients taking oral antineoplastics, non-adherence to follow-up calls was observed in more than 45% of patients receiving care from a community oncology clinic. Findings demonstrated that those with advanced stages of cancer, on commercial insurance, and going to an internal pharmacy were at higher risk for not adhering to follow up calls. Therefore, alternative methods for managing adherence and side effects in these populations are warranted.
Keyphrases
- healthcare
- palliative care
- papillary thyroid
- end stage renal disease
- quality improvement
- primary care
- mental health
- squamous cell
- affordable care act
- ejection fraction
- newly diagnosed
- chronic kidney disease
- glycemic control
- lymph node metastasis
- peritoneal dialysis
- squamous cell carcinoma
- pain management
- childhood cancer
- type diabetes
- health insurance
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- skeletal muscle
- young adults
- chronic pain
- weight loss
- breast cancer risk